In addition, head and neck cancer patients may suffer from mucositis for which analgesic therapy and antibiotics/antifungals are given in addition to drugs such as Palifermin [Keratinocyte growth factor (KGF) produced by recombinant DNA technology] to prevent infection[18]. This evidence concerns the gene FGF7 and mucositis.